A Clinical Evaluation of PROPEL® Contour Sinus Implant

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 12, 2021

Primary Completion Date

February 10, 2022

Study Completion Date

June 20, 2022

Conditions
Chronic Rhinosinusitis (Diagnosis)
Interventions
DEVICE

PROPEL Contour Sinus Implant

370 mcg mometasone furoate-coated sinus implant

PROCEDURE

Balloon Sinus Dilation Alone

No PROPEL Contour Sinus Implant

Trial Locations (14)

10016

Madison ENT, New York

30342

ENT of Georgia, Atlanta

33426

ENT & Allergy Associate of Florida, LLC, Boynton Beach

33487

ENT & Allergy Associate of Florida, LLC, Boca Raton

40205

Kentuckiana Ear, Nose & Throat PSC, Louisville

40220

Advanced ENT & Allergy, Louisville

43016

Ohio Sinus Institute, Dublin

66211

Ascentist Physicians Group, Leawood

75034

Collin County ENT, Frisco

75070

ENT Associates of Texas, McKinney

76109

Fort Worth ENT & Sinus, Fort Worth

78258

Alamo ENT Associates, San Antonio

94108

San Francisco Otolaryngology, San Francisco

95815

Sacramento ENT/DaVinci Research, LLC, Sacramento

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Intersect ENT

INDUSTRY

NCT04858802 - A Clinical Evaluation of PROPEL® Contour Sinus Implant | Biotech Hunter | Biotech Hunter